Physician profile
Hugo A Nova
NPI 1649345364
$638.96
in general payments reported to CMS, 2019-2025
10 companies · $35.37 in 2025
The $35.37 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $40.36 · 2021: $155 · 2022: $139 · 2023: $15.88 · 2024: $46.78 · 2025: $35.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $279.09 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $155.05 | 2021 | |
| Merck Sharp & Dohme LLC | $50.97 | 2019-2024 | Bridion |
| Csl Behring | $36.13 | 2019-2020 | |
| Masimo Corporation | $27.20 | 2019 | |
| Convatec INC. | $26.20 | 2024 | |
| Solventum Corporation | $21.55 | 2025 | Activ.A.C., Prevena, V.A.C. Granufoam |
| Vyaire Medical, INC. | $15.88 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $13.82 | 2025 | Exparel |
| Covidien LP | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugo Nova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.